IRIS
LUISETTI, MAURIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.795
AS - Asia 5.340
EU - Europa 4.218
SA - Sud America 641
AF - Africa 158
OC - Oceania 46
Continente sconosciuto - Info sul continente non disponibili 5
AN - Antartide 1
Totale 17.204
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.657
CN - Cina 2.712
SG - Singapore 1.174
IE - Irlanda 930
UA - Ucraina 779
DE - Germania 525
HK - Hong Kong 521
FI - Finlandia 476
BR - Brasile 471
VN - Vietnam 429
RU - Federazione Russa 383
SE - Svezia 269
FR - Francia 249
GB - Regno Unito 247
IT - Italia 150
IN - India 93
ZA - Sudafrica 76
CA - Canada 66
AR - Argentina 59
JP - Giappone 48
BD - Bangladesh 47
MX - Messico 46
IQ - Iraq 44
AU - Australia 43
BE - Belgio 34
EC - Ecuador 32
PK - Pakistan 32
NL - Olanda 27
IR - Iran 26
VE - Venezuela 25
ES - Italia 24
PT - Portogallo 24
TR - Turchia 24
PL - Polonia 21
CL - Cile 20
CO - Colombia 18
ID - Indonesia 18
PH - Filippine 18
SA - Arabia Saudita 18
UZ - Uzbekistan 17
EG - Egitto 15
MY - Malesia 15
AT - Austria 14
KE - Kenya 14
CZ - Repubblica Ceca 13
KR - Corea 13
TW - Taiwan 12
IL - Israele 11
LT - Lituania 11
MA - Marocco 11
TN - Tunisia 11
JO - Giordania 10
AL - Albania 8
AZ - Azerbaigian 8
KZ - Kazakistan 8
PY - Paraguay 8
AE - Emirati Arabi Uniti 7
DZ - Algeria 6
LB - Libano 6
TH - Thailandia 6
ET - Etiopia 5
EU - Europa 5
JM - Giamaica 5
LV - Lettonia 5
OM - Oman 5
CH - Svizzera 4
HR - Croazia 4
HU - Ungheria 4
MU - Mauritius 4
NG - Nigeria 4
NI - Nicaragua 4
PE - Perù 4
BG - Bulgaria 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
GR - Grecia 3
NO - Norvegia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PA - Panama 3
SN - Senegal 3
SY - Repubblica araba siriana 3
CR - Costa Rica 2
CY - Cipro 2
GH - Ghana 2
GT - Guatemala 2
HN - Honduras 2
KG - Kirghizistan 2
LK - Sri Lanka 2
MM - Myanmar 2
RO - Romania 2
SV - El Salvador 2
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BY - Bielorussia 1
CG - Congo 1
DK - Danimarca 1
EE - Estonia 1
Totale 17.190
Salva come PNG Salva come JPEG
Città #
Jacksonville 954
Dublin 929
Chandler 927
Nanjing 641
Singapore 554
Ashburn 532
San Jose 511
Hong Kong 501
Beijing 377
Dallas 376
Boardman 306
Nanchang 231
Princeton 199
Lawrence 192
Shenyang 192
Lauterbourg 170
Wilmington 170
Hebei 163
Changsha 158
Ho Chi Minh City 155
Jiaxing 148
Ann Arbor 147
Los Angeles 138
Hangzhou 104
Medford 101
Hanoi 97
Helsinki 93
Tianjin 91
Shanghai 79
Moscow 75
Redondo Beach 70
New York 64
Buffalo 63
Johannesburg 55
Woodbridge 52
Munich 46
Milan 43
São Paulo 41
Houston 37
Norwalk 37
The Dalles 36
Tokyo 36
Brussels 32
Frankfurt am Main 30
Falls Church 28
Orem 28
Kunming 27
Santa Clara 27
Seattle 27
Piscataway 26
Fairfield 25
Haiphong 25
Washington 25
Brooklyn 23
London 23
Verona 23
Chennai 22
Chicago 22
Da Nang 22
Atlanta 21
Des Moines 21
Baghdad 19
Dearborn 19
Denver 19
Montreal 19
Rio de Janeiro 19
Stockholm 19
Toronto 19
Warsaw 19
Phoenix 18
Tappahannock 17
Zhengzhou 16
Boston 15
Manchester 15
Melbourne 15
Tashkent 15
Mexico City 14
San Francisco 14
Columbus 13
Karachi 13
Quito 13
Turku 13
Amsterdam 12
Jinan 12
Coimbra 11
Guangzhou 11
Nairobi 11
Rome 11
Santiago 11
Belo Horizonte 10
Brisbane 10
Changchun 10
Fuzhou 10
Guayaquil 10
Hải Dương 10
Pavia 10
Brasília 9
Dhaka 9
Falkenstein 9
Jerusalem 9
Totale 10.896
Salva come PNG Salva come JPEG
Nome #
American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. 550
Matrix elastin: a promising biomarker for chronic obstructive pulmonary disease. 236
Immune Activation in α-1antitrypsin Deficiency Emphysema: Beyond the Protease/Antiprotease Paradigm. 170
Alpha1-antitrypsin in serum determined by capillary isoelectric focusing 161
Activation of Oncogenic Pathways in Idiopathic Pulmonary Fibrosis. 161
Abnormalities of Esophageal Motor Activity Are Highly Prevalent in Lung Transplanted Patients 160
"The sarcoidosis map": a joint survey of clinical and immunogenetic findings in two European countries. 150
Separation of closely related peptide substrates of human proteinases by micellar electrokinetic chromatography with anionic and nonionic surfactants. 141
Capillary electrophoresis with laser-induced fluorescence detection as a novel sensitive approach for the analysis of desmosines in real samples. 141
Short-term variability of biomarkers of proteinase activity in patients with emphysema associated with type Z alpha-1-antitrypsin deficiency. 140
Effects of 3'-hydroxyfarrerol (IdB 1031), a novel flavonoid agent, on phagocyte products 138
Alpha1-antitrypsin deficiency - diagnostic testing and disease awareness in Germany and Italy. 137
Advances in proteomic techniques for biomarker discovery in COPD 136
Assessment and management of pulmonary alveolar proteinosis in a reference center. 136
Familial elevation of serum angiotensin converting enzyme activity. 132
A Global Survey on Whole Lung Lavage in Pulmonary Alveolar Proteinosis 129
Alpha-1 antitrypsin deficiency in Italy: regional differences of the PIS and PIZ deficiency alleles. 128
A national program for detection of alpha 1-antitrypsin deficiency in Italy. Gruppo I.D.A. 122
Activity of different proteases in a complex mixture and 'in vitro' study of their reciprocal interferences by micellar electrokinetic chromatography. 122
A genome-wide association study reveals evidence of association with sarcoidosis at 6p12.1. 119
Capillary electrophoresis as a modern tool for determining proteolytic activities in purified specimens and in real samples 118
The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease? 118
Ambroxol and pulmonary toxicity induced by antineoplastic drugs. 117
A novel pharmacological approach for paraquat poisoning in rat and A549 cell line using ambroxol, a lung surfactant synthesis inducer. 117
Factors influencing oxidative imbalance in pulmonary fibrosis: an immunohistochemical study. 116
HLA markers in sarcoidosis. 116
Some properties of the alkaline proteinase from Aspergillus melleus. 116
A large kindred of pulmonary fibrosis associated with a novel ABCA3 gene variant. 115
Studies of MR 889, a new synthetic proteinase inhibitor. 114
Causal and synthetic associations of variants in the SERPINA gene cluster with alpha1-antitrypsin serum levels. 113
Inhibition of human neutrophil elastase by erythromycin andflurythromycin, two macrolide antibiotics. 112
alpha 1-antitrypsin TAQ I polymorphism and alpha 1-antichymotrypsin mutations in patients with obstructive pulmonary disease. 112
Micellar electrokinetic chromatography for the determination of urinary desmosine and isodesmosine in patients affected by chronic obstructive pulmonary disease 110
A fast amplification-reverse hybridization assay kit to detect the most frequent deficient variants in the alpha-1-antitrypsin gene. 110
Identification and characterisation of eight novel SERPINA1 null mutations. 109
Micellar electrokinetic chromatographic and capillary zone electrophoretic methods for screening urinary biomarkers of human disorders: a critical review of the state-of-the-art. 108
The cystic fibrosis gene is not likely to be involved in chronic obstructive pulmonary disease. 108
Complement receptor 1 gene polymorphisms are associated with idiopathic pulmonary fibrosis. 107
EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells. 107
C reactive protein and alpha1-antitrypsin: relationship between levels and gene variants. 106
Alpha1-antitrypsin deficiency: a report from the 2nd meeting of the Alpha One International Registry, Rapallo (Genoa, Italy), 2001. 105
Incomplete expression of epithelial-mesenchymal transition markers in idiopathic pulmonary fibrosis. 105
Inherited alpha1-antitrypsin deficiency: Is the level the key message? 105
Micellar electrokinetic chromatography: a convenient alternative to colorimetric and high performance liquid chromatographic detection for monitoring protease activity. 104
Association between markers of emphysema and more severe chronic obstructive pulmonary disease. 103
A novel method for rapid genotypic identification of alpha 1-antitrypsin variants. 103
MEKC of desmosine and isodesmosine in urine of chronic destructive lung disease patients. 102
Bioavailability of isoniazid, rifampicin and pyrazinamide (in free combination or fixed-triple formulation) in intermittent antituberculous chemotherapy. 100
Alpha1-antitrypsin deficiency. 1: epidemiology of alpha1-antitrypsin deficiency. 100
Alpha-1 antitrypsin deficiency: from Italy to the world. 100
Complement receptor 1 gene polymorphisms in sarcoidosis. 100
The Hermansky-Pudlak syndrome. A case with macrophage-neutrophil alveolitis. 100
Interactions between SERPINA1 PiMZ genotype, occupational exposure and lung function decline. 100
[American Thoracic Society/European Respiratory Society Statement: Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency]. 100
Protease-antiprotease imbalance: local evaluation with bronchoalveolar lavage. 99
α₁-Antitrypsin level and pheno/genotypes 97
Mechanisms of lung injury in cystic fibrosis. 96
Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. 96
The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma 95
Study of functional and biochemical indicators of subclinical lung damage in bleomycin-treated patients. 94
Proteomic analysis of exhaled breath condensate from single patients with pulmonary emphysema associated to alpha1-antitrypsin deficiency. 94
Alpha 1-antitrypsin variants produced by recombinant DNA: differences in elastase inhibitory activity and resistance to oxidant agents. 94
Oncogenes in non-small-cell lung cancer: emerging connections and novel therapeutic dynamics. 93
Ongoing research in Europe: Alpha One International Registry (AIR) objectives and development. 92
Pharmacokinetic studies on antituberculosis regimens in humans. I. Absorption and metabolism of the compounds used in the initial intensive phase of the short-course regimens: single administration study. 92
Proteinase/proteinase inhibitor imbalance in sputum sol phases from patients with chronic obstructive pulmonary disease. Suggestions for a key role played by antileukoprotease. 92
The role of bronchial epithelial cells in the pathogenesis of COPD in Z-alpha-1 antitrypsin deficiency. 92
Surfactant apoprotein A modulates interleukin-8 and monocyte chemotactic peptide-1 production 91
On the activity of MR 889, a new synthetic proteinase inhibitor. 90
Successful whole lung lavage in pulmonary alveolar proteinosis secondary to lysinuric protein intolerance: a case report. 90
HLA Class I, II and III polymorphisms in sarcoidosis. 89
Micellar Electrokinetic Chromatography with Laser Induced Detection and liquid chromatography tandem mass-spectrometry-based desmosine assays in urine of patients with Chronic Obstructive Pulmonary Disease: A comparative analysis. 89
High performance capillary electrophoresis in the study of proteinase activity and of markers of lung destruction. 88
Identification of a novel alpha1-antitrypsin null variant (Q0Cairo). 88
The Rapid FEV(1) Decline in Chronic Obstructive Pulmonary Disease Is Associated with Predominant Emphysema: A Longitudinal Study. 88
COPD: no gene left unturned 88
Urinary desmosine excretion in acute exacerbations of COPD: a preliminary report. 86
Call for an international survey on therapeutic lavage for pulmonary alveolar proteinosis. 85
Biochemical and functional markers of lung damage after bleomycin treatment. 85
Clinical phenotypes of Italian and Spanish patients with α1-antitrypsin deficiency. 85
Protein expression in sputum of smokers and chronic obstructive pulmonary disease patients: a pilot study by CapLC-ESI-Q-TOF. 85
SERPINA1 PiZ and PiS heterozygotes and lung function decline in the SAPALDIA cohort. 84
Lung cancer in young adults. 83
You may say that I ain't free--but it don't worry me. 83
Patient-derived granulocyte/macrophage colony-stimulating factor autoantibodies reproduce pulmonary alveolar proteinosis in nonhuman primates. 82
Eosinophilic pleural effusion due to mesalamine. Report of a rare occurrence. 82
Italian registry of patients with alpha-1 antitrypsin deficiency: General data and quality of life evaluation 82
Interactions of P 1507, a new antioxidant agent, with phagocyte functions. 81
Secondary outputs of alpha1-antitrypsin deficiency targeted detection programme. 81
Introduction: the history of the Alpha One International Registry (A.I.R.). 81
Early response of gene clusters is associated with mouse lung resistance or sensitivity to cigarette smoke. 81
HLA and sarcoidosis: new pathogenetic insights. 80
Polymorphism of angiotensin-converting enzyme gene in sarcoidosis. 80
Sarcoidosis of the thyroid: report of a case and a review of the literature. 80
Whole lung lavage therapy of pulmonary alveolar proteinosis: a global survey of current practices and procedures 80
Respiratory Proteomics Today: Are Technological Advances for the Identification of Biomarker Signatures Catching up with Their Promise? A Critical Review of the Literature in the Decade 2004–2013. 80
Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis. 79
Interactions of alpha-1-antichymotrypsin, alpha-1-proteinase inhibitor, and alpha-2-macroglobulin with the fungal enzyme, seaprose. 79
Primary lung adenocarcinoma: characteristics by smoking habit and sex. 79
Report of one case of familial sarcoidosis. 78
Totale 10.973
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.557
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.557
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021447 0 0 0 0 0 0 0 0 0 215 191 41
2021/2022727 18 5 5 16 17 26 22 60 49 10 126 373
2022/20232.658 284 184 19 225 319 276 0 153 1.061 22 71 44
2023/2024955 102 180 43 67 109 199 14 50 8 68 73 42
2024/20252.422 80 225 70 121 51 89 83 249 559 83 244 568
2025/20265.137 366 379 710 647 632 281 1.098 187 484 353 0 0
Totale 17.284